Anish Bhatnagar

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$31,745.00
Insider Sells Quantity
13
Insider Sells Sum
$19.65M

Insider Activity of Anish Bhatnagar

According to the SEC Form 4 filings, Anish Bhatnagar, being in a position of

  1. CHIEF EXECUTIVE OFFICER at Soleno Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 479373 shares for $19.63M,
    over all time since 2015-08-12, has bought 85000 shares for $31,745, and sold 518406 shares for $19.65M.

The largest purchase of all time was on 2015-08-12 and amounted to 10000 shares of Soleno Therapeutics, Inc. for $16,400.

The largest sale of all time was on 2023-12-11 and amounted to 93408 shares of Soleno Therapeutics, Inc. for $3.33M.

Biography of Anish Bhatnagar

No biography is available at this moment.

2024-10-01SaleSoleno Therapeutics, Inc.
SLNO
CHIEF EXECUTIVE OFFICER
21,633
0.0564%
$49.43$1.07M+10.07%
2024-08-29SaleSoleno Therapeutics, Inc.
SLNO
CHIEF EXECUTIVE OFFICER
58,391
0.1525%
$47.28$2.76M+13.46%
2024-08-28SaleSoleno Therapeutics, Inc.
SLNO
CHIEF EXECUTIVE OFFICER
56,613
0.1474%
$47.58$2.69M+12.32%
2024-08-06SaleSoleno Therapeutics, Inc.
SLNO
CHIEF EXECUTIVE OFFICER
69,131
0.1847%
$45.46$3.14M+10.02%
2024-08-05SaleSoleno Therapeutics, Inc.
SLNO
CHIEF EXECUTIVE OFFICER
58,213
0.1616%
$45.77$2.66M+13.07%
2024-07-01SaleSoleno Therapeutics, Inc.
SLNO
CHIEF EXECUTIVE OFFICER
19,256
0.0555%
$41.54$799,8440%
2024-04-01SaleSoleno Therapeutics, Inc.
SLNO
CHIEF EXECUTIVE OFFICER
18,980
0.0583%
$41.34$784,645+12.86%
2024-01-25SaleSoleno Therapeutics, Inc.
SLNO
CHIEF EXECUTIVE OFFICER
2,527
0.0086%
$48.30$122,054+0.45%
2023-12-11SaleSoleno Therapeutics, Inc.
SLNO
Chief Executive Officer
93,408
0.311%
$35.67$3.33M+31.13%
2023-11-30SaleSoleno Therapeutics, Inc.
SLNO
Chief Executive Officer
27,716
0.0882%
$28.65$794,116+55.55%
2023-11-29SaleSoleno Therapeutics, Inc.
SLNO
Chief Executive Officer
27,827
0.0897%
$27.83$774,535+61.48%
2023-11-28SaleSoleno Therapeutics, Inc.
SLNO
Chief Executive Officer
25,678
0.0837%
$27.12$696,514+67.02%
2022-03-31PurchaseSoleno Therapeutics, Inc.
SLNO
Chief Executive Officer
60,000
$0$0-32.29%
2022-01-21SaleSoleno Therapeutics, Inc.
SLNO
Chief Executive Officer
39,033
0.0488%
$0.37$14,559-54.87%
2016-08-19PurchaseSoleno Therapeutics, Inc.
SLNO
See Remarks
10,000
0.0586%
$0.96$9,600-25.96%
2016-05-13PurchaseSoleno Therapeutics, Inc.
SLNO
President and CEO
5,000
0.0314%
$1.15$5,745-20.34%
2015-08-12PurchaseSoleno Therapeutics, Inc.
SLNO
See Remarks
10,000
0.1002%
$1.64$16,400-20.25%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.